US Patent Issued to HANGZHOU GONGCHU BIOTECHNOLOGY on Nov. 11 for "Striatin interacting protein inhibitor and use thereof in preparation of anti-tumor drug" (Chinese Inventor)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,467,052, issued on Nov. 11, was assigned to HANGZHOU GONGCHU BIOTECHNOLOGY Co. LTD. (Hangzhou, China).

"Striatin interacting protein inhibitor and use thereof in preparation of anti-tumor drug" was invented by Gongchu Li (Zhejiang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to the field of biomedical engineering technology, and provides the application of striatin interacting protein (STRIP) inhibitors in the preparation of anti-tumor drugs, recombinant vectors of STRIP inhibitors and their application in the preparation of anti-tumor drugs, and anti-tumor pharmaceutical compositions in which STRIP inhibitors or recombin...